- Home
- CEV vs INCR Comparison
CEV vs INCR Comparison
Compare CEV & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEV
- INCR
- Stock Information
- Founded
- CEV 1999
- INCR 1994
- Country
- CEV United States
- INCR Israel
- Employees
- CEV N/A
- INCR N/A
- Industry
- CEV Finance/Investors Services
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- CEV Finance
- INCR Health Care
- Exchange
- CEV Nasdaq
- INCR Nasdaq
- Market Cap
- CEV 71.8M
- INCR 76.7M
- IPO Year
- CEV N/A
- INCR N/A
- Fundamental
- Price
- CEV $9.62
- INCR $1.38
- Analyst Decision
- CEV
- INCR
- Analyst Count
- CEV 0
- INCR 0
- Target Price
- CEV N/A
- INCR N/A
- AVG Volume (30 Days)
- CEV 19.6K
- INCR 18.5K
- Earning Date
- CEV 01-01-0001
- INCR 04-29-2025
- Dividend Yield
- CEV 4.23%
- INCR N/A
- EPS Growth
- CEV N/A
- INCR N/A
- EPS
- CEV 0.36
- INCR N/A
- Revenue
- CEV N/A
- INCR $72,420,918.00
- Revenue This Year
- CEV N/A
- INCR N/A
- Revenue Next Year
- CEV N/A
- INCR $39.30
- P/E Ratio
- CEV $29.36
- INCR N/A
- Revenue Growth
- CEV N/A
- INCR N/A
- 52 Week Low
- CEV $8.83
- INCR $1.17
- 52 Week High
- CEV $10.91
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- CEV 36.08
- INCR 47.53
- Support Level
- CEV $9.31
- INCR $1.27
- Resistance Level
- CEV $10.19
- INCR $1.31
- Average True Range (ATR)
- CEV 0.13
- INCR 0.06
- MACD
- CEV -0.03
- INCR 0.01
- Stochastic Oscillator
- CEV 35.23
- INCR 73.90
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.